Literature DB >> 8838134

Sequential appearance of inflammatory mediators in rat bronchoalveolar lavage fluid after oleic acid-induced lung injury.

S Syrbu1, R S Thrall, H M Smilowitz.   

Abstract

The oleic acid (OA) model of rat lung injury was originally developed as a model of fat embolism syndrome. A single intravenous dose of pure OA causes an acute diffuse lung injury, which, in its initial stages, histologically and physiologically resembles human ARDS. Rat lungs acutely injured by intravenous OA manifest increased levels of ICAM-1 within 30-60 min. This study shows that human umbilical vein endothelial cells (HUVEC) can be used in a bioassay to reveal some of the adhesion molecule stimulating activities present in bronchoalveolar lavage fluid (BALF) from post-OA-injected rats: (1) There is an as yet unidentified ICAM-1 and ELAM (E Selectin) inducing activity in BALF within 15 min of OA injection that is not TNF alpha; there is very little measurable tumor necrosis factor-alpha (TNF alpha) in 15 min BALF (BALF15). (2) BALF15 also stimulates cultured macrophage derived from BALF of normal rat lungs to produce TNF alpha. (3) By 60 min after OA injection, 50-75% of the ICAM-1 and ELAM inducing activity in BALF (BALF60) is TNF alpha; BALF60 contains about 250-280 pg/mL TNF alpha. The other 25-50% adhesion molecule-inducing activity in BALF60 is unidentified. (4) The ICAM-1-inducing activity of pure TNF alpha was equal to that of BALF60 containing equivalent concentrations of TNF alpha. The ELAM inducing activity of pure TNF alpha, however, was about 1/2 that of BALF60 containing equivalent concentrations of TNF alpha. The time courses for ICAM and ELAM stimulation with pure TNF alpha or BALF60 containing equivalent levels of TNF alpha were the same. The identity of the mediators in BALF15 and BALF60 that are not TNF alpha and the mechanisms by which OA injection stimulates cytokine production remain to be elucidated.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8838134     DOI: 10.3109/01902149609074016

Source DB:  PubMed          Journal:  Exp Lung Res        ISSN: 0190-2148            Impact factor:   2.459


  5 in total

1.  Role of interleukin-6 as an early marker of fat embolism syndrome: a clinical study.

Authors:  Shiva Prakash; Ramesh Kumar Sen; Sujit Kumar Tripathy; Indu Mohini Sen; R R Sharma; Sadhna Sharma
Journal:  Clin Orthop Relat Res       Date:  2013-02-20       Impact factor: 4.176

2.  Effect of continuous hemofiltration on hemodynamics, lung inflammation and pulmonary edema in a canine model of acute lung injury.

Authors:  Xiao Su; Chunxue Bai; Qunying Hong; Duming Zhu; Lixian He; Jianping Wu; Feng Ding; Xiaohui Fang; Michael A Matthay
Journal:  Intensive Care Med       Date:  2003-10-14       Impact factor: 17.440

3.  Regulation of hypothalamic-pituitary-adrenal axis by circulating free fatty acids in male Wistar rats: role of individual free fatty acids.

Authors:  Young Taek Oh; Jinyub Kim; Insug Kang; Jang H Youn
Journal:  Endocrinology       Date:  2013-12-11       Impact factor: 4.736

4.  Renin-Angiotensin Blockade Reduces Readmission for Acute Chest Syndrome in Sickle Cell Disease.

Authors:  Nneoma Wamkpah; Anuj Shrestha; Gary Salzman; Stephen Simon; Sahil Suman; Alan Poisner; Agostino Molteni
Journal:  Cureus       Date:  2022-03-28

5.  Interleukin-6 as an early marker for fat embolism.

Authors:  R Yoga; Jc Theis; M Walton; W Sutherland
Journal:  J Orthop Surg Res       Date:  2009-06-13       Impact factor: 2.359

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.